Inhaled corticosteroids (ICS) are the preferred method of therapy for persistent asthma in children, providing the most effective anti-inflammatory treatment available. This article defines treatment with ICS in children and discusses current research findings related to the long-term side effects and safety concerns related to ICS therapy in children with asthma. Major safety concerns associated with long-term treatment with ICS include the potential effect on adrenal function, the inhibition of linear growth and growth velocity, osteoporosis, and ocular disorders. This article describes side effects associated with ICS and implications in pediatric primary care.
US Department of Health and Human Services, Centers for Disease Control and Prevention. Summary health statistics for U.S. children: National Health Interview Survey, 2009. Vital Health Stat. 2010;(247):1-149. http://www.cdc.gov/nchs/data/series/sr_10/sr10_247.pdf. Accessed January 13, 2011.
2.
National Heart, Lung, and Blood Institute, National Institutes of Health. National Asthma Education and Prevention Program: Expert panel report 3: Guidelines for the diagnosis and management of asthma. Rockville, MD: US Department of Health and Human Resources. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed March 3, 2008.
AllenDBieloryLDerendorfHDluhyRColiceGLSzeflerSJ. Inhaled corticosteroids: past lessons and future issues. J Allergy Clinical Immunol. 2003;112(3 suppl):S1-S40.
5.
DahlR. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006;100:1307-1317.
6.
PedersenS. Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials. Drug Saf. 2006;29:599-612.
7.
Childhood Asthma Management Program Research Group. The long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;18:1054-1063.
8.
AgertoftLPederseS. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000;343:1064-1069.
9.
SkonerDPSzeflerSJWelchMWalton-BowenKCruz-RiveraMSmithJA. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol. 2000;105:259-268.
10.
RouxCKoltaSDesfougeresJMininiPBidatE. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics. 2003;111:e706-e713.
11.
de BenedictisFMedleyHWilliamsL. Long term study to compare safety and efficacy of fluticasone propionate (FP) with beclomethasone dipropionate (BDP) in asthmatic children. Eur Respir J. 1998;12:S142.
12.
PedersenS. Childhood asthma and growth. In: SchleimerR, ed. Inhaled Steroids in Asthma: Optimizing Effects in the Airways. New York, NY: Marcel Dekker; 2002:353-358.
13.
AllenD. Safety of inhaled corticosteroids in children. Pediatr Pulmonol. 2002;33:208-220.
14.
MartinRSzeflerSChinchilliV. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med. 2002;165:1377-1383.
15.
ToddGAceriniCRoss-RussellRZahraSWarnerJTMcCanceD. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;8:457-461.
16.
Van StaaTPLeukfensHGMCooperC. Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res. 2001;16:581-587.
17.
SchliengerRJickSMeierC. Inhaled corticosteroids and the risk of fractures in children and adolescents. Pediatrics. 2004;114:469-473.
18.
MakVHMelchorRSpiroSG. Easy bruising as a side-effect of inhaled corticosteroids. Eur Respir J. 1992;5:1068-1074.
